Gadobutrol Enhanced MRA of the Supra-aortic Vessels "GEMSAV"


Phase 3 Results

Summary of Purpose

Subjects referred for a routine CTA (computed tomography angiography) or MRA (magnetic resonance angiography) will be invited to participate in the study and subjects will be involved in the study for between 2 and 12 days. Two to three visits to the study doctor will be required. This study will compare the diagnostic results of Gadobutrol enhanced MRA images with MRA images taken without contrast agent...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 July 2015.

1 May 2011 5 Apr 2011 1 May 2014 1 May 2014 1 Jul 2015 27 May 2015
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Diagnostic
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment